PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Infertility: An overview • Epidemiology • Signs and symptoms • Tests and diagnosis • Treatments PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Stages of fertility treatment PART 07: Regulatory landscape of ART and IVF • Reporting requirements • Regulations governing IVF • Need for more guidelines and regulations PART 08: Fertility tourism PART 09: Cost analysis • Direct costs • Indirect costs • Cost of IVF treatments PART 10: Market segmentation by type of treatment • Infertility drugs • Global infertility drugs market • ART • Global ART market PART 11: Geographical segmentation • Fertility services market in Americas • Fertility services market in EMEA • Fertility services market in APAC PART 12: Key leading countries • US • UK • Belgium • China • India • Israel PART 13: Market drivers • Increase in infertility rate and obesity • Increase in success rate of infertility treatments • Growing demand for ART and acceptance of same-sex marriage in developed countries PART 14: Impact of drivers PART 15: Market challenges • High cost of fertility treatments • Complications related to fertility services • Ethical, legal, and social issues • Limited reimbursement PART 16: Impact of drivers and challenges PART 17: Market trends • Increase in R&D • Establishment of new fertility clinics • Increase in M&A and collaborations • Public awareness and government support • Medical tourism PART 18: Vendor landscape • Competitive scenario • Key news • Mergers and acquisitions • Licenses and collaborations • Key vendor analysis 2015 • Other prominent vendors PART 19: Appendix • List of abbreviations PART 20: Explore Technavio   Exhibit 01: Product offerings Exhibit 02: Causes of male infertility Exhibit 03: Etiologies of female infertility Exhibit 04: Infertility in people aged 35 and above in US 2002 and 2010 Exhibit 05: Global fertility services market 2015-2020 ($ billions) Exhibit 06: Five forces analysis Exhibit 07: Stages of fertility treatment Exhibit 08: Assessment of regulatory landscape Exhibit 09: Fertility tourism: Major hotspots Exhibit 10: Number of visitors to fertility clinics in medical tourism hotspots worldwide 2013-2015 Exhibit 11: Average cost of hormonal stimulation in IVF by age ($) Exhibit 12: Cost analysis of IVF by various stages in US Exhibit 13: Segmentation of global fertility services market by type of treatment Exhibit 14: Segmentation of infertility drug usage by geography 2015 Exhibit 15: Global infertility drugs market 2015-2020 ($ billions) Exhibit 16: Types of ART procedures Exhibit 17: Segmentation based on adoption of ART procedures in US 2015 Exhibit 18: IVF procedure Exhibit 19: Success rate of IVF Exhibit 20: Segmentation based on adoption of ART by geography 2015 Exhibit 21: Global ART market 2015-2020 ($ billions) Exhibit 22: Segmentation of global fertility services market by geography 2015 Exhibit 23: Fertility services market in Americas 2015-2020 ($ billions) Exhibit 24: Number of ART cycles in Americas Exhibit 25: Fertility services market in EMEA 2015-2020 ($ billions) Exhibit 26: Number of ART cycles in EMEA Exhibit 27: Fertility services market in APAC 2015-2020 ($ billions) Exhibit 28: Number of ART cycles in APAC Exhibit 29: Married women with primary infertility in US 1965-2010 Exhibit 30: Causes of infertility in UK 2009 Exhibit 31: Percentage of infertility among couples attempting pregnancy 2012 Exhibit 32: Population of women of reproductive age (20-44 years) in billions 2015 Exhibit 33: Segmentation of fertility rate among women by age 2014 Exhibit 34: Obesity-related fertility issues Exhibit 35: Impact of drivers Exhibit 36: Average cost of various fertility services worldwide Exhibit 37: Reimbursement scenario in Americas Exhibit 38: Reimbursement scenario in Europe Exhibit 39: Reimbursement scenario in Asia Exhibit 40: Impact of drivers and challenges Exhibit 41: Number of fertility clinics worldwide 2012 Exhibit 42: Recent M&A Exhibit 43: Stakeholders involved in fertility services Exhibit 44: Some trends in global fertility services market Exhibit 45: CARE Fertility: Key takeaways Exhibit 46: CooperSurgical: Business segmentation by revenue 2014 Exhibit 47: CooperSurgical: Business segmentation by revenue 2013 and 2014 ($ millions) Exhibit 48: CooperSurgical: Key takeaways Exhibit 49: Ferring Pharmaceuticals: Business segmentation Exhibit 50: Ferring Pharmaceuticals: Key takeaways Exhibit 51: Monash IVF: Business segmentation by revenue 2015 Exhibit 52: Monash IVF: Geographical segmentation by revenue 2015 Exhibit 53: Monash IVF: Key takeaways Exhibit 54: Merck: Business segmentation by revenue 2014 Exhibit 55: Merck: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 56: Merck: Geographical segmentation by revenue 2014 Exhibit 57: Merck: Key drivers in fertility services sector Exhibit 58: Merck: Key takeaways Exhibit 59: Vitrolife: Geographical segmentation by revenue 2014 Exhibit 60: Vitrolife: Key takeaways Exhibit 61: Drug manufacturing companies Exhibit 62: Equipment and media developing companies Exhibit 63: Fertility service providers

Carefertility, Coopersurgical, Ferring Pharmaceuticals, Merck, MonashIVF, Vitrolife, Abbott Laboratories, AbbVie, Actavis, Apricus Biosciences, AstraZeneca, Auxogyn, Bristol-Myers Squibb, Cell Cura, Dong-A Socio, Elelixis Diagnostics, Eli Lilly, EMD Serono, Fertility Focus, Halotech, HRA Pharma, IKS International, In Vitro Care, Invo Bioscience, Irvine Scientific, IVFtech Aps, Kitazato, Life Global, Medical Electronic Systems, Meditex, Microtech IVF, Nidacon International, Novartis, NuSep, Ovascience, Pantec Biosolutions, Pfizer, PregLem, Reproductive Health Science, ReproTech, Sanofi, Smiths Medical International, Sperm Processor, Vitrolife, Vivus, Xytex Cryo International.